Gisela D'Angelo

Dr. Gisela D'Angelo

Institute Curie, Paris, Île-de-France, France

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 August 2021 in Nature Methods
Verified
Journal Article
Closed access
PDF file
FVFrederik J. Verweij
Frederik J. Verweij
Leonora BalajLeonora Balaj
Leonora Balaj
CBChantal M. Boulanger
Chantal M. Boulanger
DCDavid R. F. Carter
David R. F. Carter
ECEwoud B. Compeer
Ewoud B. Compeer
Guillaume Van NielGuillaume Van Niel
Guillaume Van Niel

1 April 2021 in Current Biology
Verified
Journal Article
Open access
SASophie D. Adams
Sophie D. Adams
JCJudit Csere
Judit Csere
GDGisela D'Angelo
Gisela D'Angelo
ECEdward P. Carter
Edward P. Carter
MRMaryse Romao
Maryse Romao
SGSusana A. Godinho
Susana A. Godinho
Bidirectional communication between cells and their surrounding environment is critical in both normal and pathological settings. Extracellular vesicles (EVs), which facilitate the horizontal transfer of molecules between cells, are recognized as an important constituent of cell-cell communication. In cancer, alterations in EV secretion contribute to the growth and metastasis of tumor cells. However, the mechanisms underlying these changes remain largely unknown. Here, we show that centrosome amplification is associated with and sufficient to promote small extracellular vesicle (SEV) secretion in pancreatic cancer cells. This is a direct result of lysosomal dysfunction, caused by increased reactive oxygen species (ROS) downstream of extra centrosomes. We propose that defects in lysosome function could promote multivesicular body fusion with the plasma membrane, thereby enhancing SEV secretion. Furthermore, we find that SEVs secreted in response to amplified centrosomes are functionally distinct and activate pancreatic stellate cells (PSCs). These activated PSCs promote the invasion of pancreatic cancer cells in heterotypic 3D cultures. We propose that SEVs secreted by cancer cells with amplified centrosomes influence the bidirectional communication between the tumor cells and the surrounding stroma to promote malignancy.

1 January 2022 in Current Biology
Verified
Journal Article
Closed access
IHIlse Hurbain
Ilse Hurbain
AMAnne-Sophie Macé
Anne-Sophie Macé
MRMaryse Romao
Maryse Romao
EPElodie Prince
Elodie Prince
LSLucie Sengmanivong
Lucie Sengmanivong
GDGisela D'Angelo
Gisela D'Angelo

12 April 2024 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
MPMarie-Thérèse Prospéri
Marie-Thérèse Prospéri
CGCécile Giordano
Cécile Giordano
MGMireia Gomez-Duro
Mireia Gomez-Duro
IHIlse Hurbain
Ilse Hurbain
AMAnne-Sophie Macé
Anne-Sophie Macé
GDGisela D'Angelo
Gisela D'Angelo
Extracellular vesicles (EVs) facilitate the transfer of proteins, lipids, and genetic material between cells and are recognized as an additional mechanism for sustaining intercellular communication. In the epidermis, the communication between melanocytes and keratinocytes is tightly regulated to warrant skin pigmentation. Melanocytes synthesize the melanin pigment in melanosomes that are transported along the dendrites prior to the transfer of melanin pigment to keratinocytes. EVs secreted by keratinocytes modulate pigmentation in melanocytes [(A. Lo Cicero et al. , Nat. Commun. 6 , 7506 (2015)]. However, whether EVs secreted by keratinocytes contribute to additional processes essential for melanocyte functions remains elusive. Here, we show that keratinocyte EVs enhance the ability of melanocytes to generate dendrites and mature melanosomes and promote their efficient transfer. Further, keratinocyte EVs carrying Rac1 induce important morphological changes, promote dendrite outgrowth, and potentiate melanin transfer to keratinocytes. Hence, in addition to modulating pigmentation, keratinocytes exploit EVs to control melanocyte plasticity and transfer capacity. These data demonstrate that keratinocyte-derived EVs, by regulating melanocyte functions, are major contributors to cutaneous pigmentation and expand our understanding of the mechanism underlying skin pigmentation via a paracrine EV-mediated communication.

14 March 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
RAReid Aikin
Reid Aikin
ACAlexandra Cervantes
Alexandra Cervantes
GDGisela D'Angelo
Gisela D'Angelo
LRLaurent Ruel
Laurent Ruel
SLSandra Lacas-Gervais
Sandra Lacas-Gervais
PTPascal Thérond
Pascal Thérond
Hedgehog (Hh) proteins are secreted molecules that function as organizers in animal development. In addition to being palmitoylated, Hh is the only metazoan protein known to possess a covalently-linked cholesterol moiety. The absence of either modification severely disrupts the organization of numerous tissues during development. It is currently not known how lipid-modified Hh is secreted and released from producing cells. We have performed a genome-wide RNAi screen in Drosophila melanogaster cells to identify regulators of Hh secretion. We found that cholesterol-modified Hh secretion is strongly dependent on coat protein complex I (COPI) but not COPII vesicles, suggesting that cholesterol modification alters the movement of Hh through the early secretory pathway. We provide evidence that both proteolysis and cholesterol modification are necessary for the efficient trafficking of Hh through the ER and Golgi. Finally, we identified several putative regulators of protein secretion and demonstrate a role for some of these genes in Hh and Wingless (Wg) morphogen secretion in vivo. These data open new perspectives for studying how morphogen secretion is regulated, as well as provide insight into regulation of lipid-modified protein secretion.

9 December 2022 in Biochemical Society Transactions
Verified
Journal Article
Closed access
PDF file
CMCharlène Martin
Charlène Martin
MBMathilde Bergamelli
Mathilde Bergamelli
CMCécile E. Malnou
Cécile E. Malnou
GDGisela D'Angelo
Gisela D'Angelo
For several years, a growing number of studies have highlighted the pivotal role of placental extracellular vesicles (EVs) throughout pregnancy. These membrane nanovesicles, heterogeneous in nature, composition and origin, are secreted by several trophoblastic cell types and are found in both the maternal and fetal compartments. They can be uptaken by recipient cells and drive a wide variety of physiological and pathological processes. In this review, we provide an overview of the different described roles of placental EVs in various aspects of normal pregnancy, from placenta establishment to maternal immune tolerance towards the fetus and protection against viral infections. In the second part, we present selected examples of pathological pregnancies in which placental EVs are involved, such as gestational diabetes mellitus, pre-eclampsia, and congenital infections. Since the abundance and/or composition of placental EVs is deregulated in maternal serum during pathological pregnancies, this makes them interesting candidates as non-invasive biomarkers for gestational diseases and opens a wide field of translational perspectives.